Antibiotic resistance is the unavoidable result of our placing selective pressure on the microbial community. Advances in molecular biology techniques in the past 2 decades have allowed us to greatly improve our understanding of the mechanisms by which resistance emerges and disseminates among human pathogenic bacteria. Gram-positive bacteria employ a diverse array of elements, including plasmids, transposons, insertion sequences, and bacteriophages, to disseminate resistance. An understanding of these mechanisms and their prevalence can improve our ability to treat clinical infections in hospitalized patients, as well as to predict and control the spread of resistant bacteria in the nosocomial environment.
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Bill Gates and his colleagues have run afoul of federal regulators by "bundling" Microsoft software products with their operating system, thereby ensuring wide use of and familiarity with their products. This strategy of packaging with intended purchases products that have not specifically been ordered is used by bacteria to great advantage. By packaging several resistance determinants together, these resourceful human pathogens promote the persistence and dissemination of a wide range of resistance genes under a variety of selective pressures.
The growing problem of antimicrobial resistance in bacteria pathogenic for humans has important implications for morbidity and mortality in hospitalized patients as well as for the rising cost of delivering medical care to our citizens. Early models of person-to-person spread of clonally related bacteria expressing a single resistance determinant have given way in recent years to outbreaks characterized by polyclonal and multidrug-resistant bacteria. These observations suggest the ability on the part of bacteria to concentrate and exchange important antimicrobial resistance determinants. In this article, I will provide an overview of the mechanisms by which grampositive bacteria assemble and disseminate antimicrobial resistance determinants and discuss the implications that these mechanisms have for treatment strategies for infected patients.
The discussion of mobile elements must employ molecular biology terminology that is not always familiar to the clinician. In an attempt to address the confusion that may result from the use of these terms, I have included a table of definitions for the terms used in this article (table 1) . It is hoped that this table will provide an easy reference for understanding the text of this article.
Why Should We Care About the Mechanisms by Which Resistance Genes Transfer?
Widely available rapid identification of and susceptibility testing for clinical isolates raises the following question: does knowledge of the mechanisms of resistance transfer really matter? After all, once a complete susceptibility profile is available, our antibiotic choices, or lack of them, are obvious. I think that there are several reasons why a more thorough understanding of transfer mechanisms can improve our ability to treat and control infectious diseases.
The ability to predict linkages of different resistance determinants. Appropriate empirical treatment of infectious diseases presupposes the ability to predict the antimicrobial susceptibility of the likely pathogen(s). Knowing the likelihood that different resistance determinants will occupy the same transferable element can help avoid the use of ineffective antibiotics based on assumed susceptibility. Because all resistance phenotypes are not detectable in the same time frame, the knowledge of the genetic underpinnings of transmission can avert ineffective therapeutic choices. For example, b-lactamase production in enterococci is usually plasmid encoded. With very few exceptions, these plasmids also encode high-level resistance to gentamicin [1] . The b-lactamase assay used in clinical lab- The total number of transposons is the same after transposition as before (the element leaves one place and enters another).
Replicative
The number of transposons is increased from the number at the start (the transposon links up with its target without leaving its original home, makes a copy while the two regions are attached, and then resumes the original position, with a second copy at the target site).
NOTE. As the broad array of mobile elements detailed in the above list emphasizes, the first casualty in any consideration of bacteria should be the concept that bacterial genomes are fixed entities. The conception of a bacterium that can multiply (with the attendant potential for mutation, deletion, or duplication of DNA) every 20 min, absorb foreign DNA by a variety of mechanisms (conjugation, transduction, and transformation), and recombine acquired DNA with a variety of host structures inspires images of a versatile and constantly moving target, superbly positioned to adapt to challenges presented by the external environment. Our use of antibiotics is but one of the many challenges faced by bacteria over the ages, and it is therefore not surprising that their response to this challenge has been swift and breathtaking in its complexity.
oratories is based on a change in color of the chromogenic cephalosporin nitrocefin that takes minutes to interpret. In contrast, the determination of high-level gentamicin resistance takes 24 h. Knowledge that an enterococcal strain produces blactamase can be used to predict gentamicin resistance and, therefore, avert potentially toxic and ineffective therapy from being administered.
Understanding coselective pressures. One of the more curious associations of the recent decade has been the almost universal association of vancomycin resistance with high-level ampicillin resistance in Enterococcus faecium [2] . In some geographic areas, this association is explained by the integration of a VanB transposon into a larger mobile element that encodes penicillin-binding protein 5-mediated resistance to ampicillin [3] . A curious clinical association that has been repeatedly observed is that between the use of extended-spectrum cephalosporins and the increased risk of infection and colonization with vancomycin-resistant enterococci (VRE) [4, 5] . There is little reason to believe that cephalosporins select specifically for vancomycin resistance. However, it was noted before the era of VRE that extended-spectrum cephalosporins were associated with colonization by ampicillin-resistant E. faecium [6] . Therefore, the most likely explanation for the association between cephalosporin and VRE is the association between vancomycin resistance and ampicillin resistance.
Prediction of resistance phenotypes that may not be reliably detected by using phenotypic techniques.
The transposon Tn917 confers erythromycin resistance in enterococci and other streptococci by expression of the ermAM gene [7] . In Tn917, the expression of ermAM is inducible by exposing cells to erythromycin. Once expressed, ermAM also confers resistance to clindamycin. However, clindamycin does not induce expression of the resistance. Tn917-containing strains may therefore appear susceptible to clindamycin in vitro. Mutation to constitutive expression does occur, however, resulting in clindamycin resistance. As a result, if one suspects Tn917-mediated erythromycin resistance, the use of clindamycin for therapy should be avoided, despite in vitro results suggesting susceptibility.
Understanding transmission patterns within hospitals. Strict infection control measures, such as isolation of patients, gown and glove use by people coming into contact with patients, and surveillance cultures to identify carriers of resistant bacteria, have been shown to be effective in controlling the spread of methicillin-resistant Staphylococcus aureus in the hospital setting [8] . Molecular analysis of methicillin-resistant S. aureus strains suggests that their spread is clonal and that the determinant that confers this resistance (mecA) is rarely if ever transferable to other staphylococci. In contrast, several large outbreaks of VRE have been affected only minimally by implementation of strict infection control measures [9, 10] . Molecular analyses of strains isolated in these outbreaks have confirmed the presence of vancomycin resistance determinants in a large number of different strains of VRE, a finding supported by the transferability of the determinants to enterococcal recipients in vitro. At the same time, studies have suggested that reducing antibiotic selective pressure, specifically with use of extended-spectrum cephalosporins, may have a significant impact on the prevalence of VRE [4, 5] . Understanding the transmissibility of different resistance determinants may help tailor strategies (and perhaps even preserve scarce resources) by predicting the likely success of a given strategy for controlling certain types of resistance.
In summary, where microorganisms are concerned, knowledge is power. If it were our job to topple a large apartment building in a manner that minimized the use of dynamite and maximized the chance of a controlled collapse, then a thorough knowledge of the structure of the building would be critical to our success. Similarly, the likelihood that we will be successful in treating clinical infections will be enhanced if our treatment strategies are informed by a detailed knowledge of the bacterial causes of the infection being treated.
Mechanisms for Stockpiling Resistance Genes in GramPositive Bacteria
The ability to concentrate multiple resistance determinants within a circumscribed mobile genetic region greatly facilitates their dissemination. In gram-negative bacteria, regions known as integrons appear to be important mechanisms for concentrating resistance genes [11] . Although integron-like structures have recently been described in enterococci, the more common mechanism for concentrating resistance genes in genera of gram-positive bacteria appears to be the use of insertion sequences and transposons. A particularly illustrative example of this phenomenon is Tn5385, a transferable chromosomal unit found in some strains of Enterococcus faecalis [12] [13] [14] [15] .
The structure of Tn5385 is shown in figure 1 . This mobile element was first described in strains of E. faecalis isolated during an outbreak of b-lactamase-producing enterococci at Children's Hospital in Boston [16, 17] . The initial recognition that the b-lactamase genes in these strains were chromosomally encoded yet transferable led to a more detailed examination of the transferable element. Tn5385 is an element that is ∼65 kilobases (kb) whose ends are directly repeated copies of the insertion sequence IS1216 (IS1216 is found frequently in enterococci, often integrated within or near the VanA-encoding vancomycin resistance transposon Tn1546 [18] ). The left-end IS1216 of Tn5385 flanks an open reading frame with 97% identity to an open reading frame from pSM19035 isolated from a strain of Streptococcus pyogenes, suggesting that this region was possibly derived from this species [15] . To the right of this open reading frame is the aadE gene, which encodes high-level resistance to streptomycin (Sm on figure 1 ). To the right of the aadE gene is Tn5381, a conjugative transposon that is nearly identical to Tn916 (the prototype for this type of transposon) [12] . Conjugative transposons are found commonly in entero- cocci and in streptococcal species and exhibit a very broad host range in laboratory matings [19] .
To the right of Tn5381 in Tn5385 lies a third copy of IS1216. To the right of this IS1216 lie sequences 72% identical to the relaxase gene of the small, potentially mobilized staphylococcal plasmid pS194 (Mob on figure 1), suggesting that this copy of IS1216 had mediated a cointegration between streptococcal and staphylococcal plasmids [20] . To the right of the staphylococcal sequences within Tn5385 lies a structure indistinguishable from Tn4001, a composite gentamicin resistance transposon that is composed of the aac-6 -aph-2 bifunctional aminoglycoside resistance gene flanked by inverted copies of IS256 [21] . Tn4001-like transposons, although first described in S. aureus, have been found widely distributed in staphylococcal and streptococcal species. The right end of Tn4001 within Tn5385 interrupts sequences identical to the replication region of the broad host range plasmid pAMb1 [22] (originally described in enterococci), which itself has been interrupted by a deletion derivative of the enterococcal erythromycin resistance transposon Tn917. It would be predicted that this replication region would be nonfunctional, since the region known to be the origin of pAMb1 replication has been deleted by the insertion of IS256 [22] . To the right of the replication region gene repC lay directly repeated copies of the staphylococcal insertion sequence element IS257 flanking a mercury resistance operon (Mer on figure  1 ). To the right of the second IS257 copy lay sequences identical to those found on staphylococcal b-lactamase plasmids, including a version of the b-lactamase transposon Tn552 [23] (Bla on figure 1) whose regulatory gene blaR1 has been inserted into by a copy of IS256 [24] .
Although it is not possible to precisely reconstruct the events that led to the formation of Tn5385, its structure suggests some tantalizing possibilities. The primary players in this evolution are most likely pAMb1 (the broad host range plasmid) and IS1216. One can envision the IS1216-containing variant of pAMb1 traveling from an Enterococcus to a S. pyogenes strain and cointegrating with an aadE-and Tn5381-containing streptococcal plasmid through the action of IS1216. This composite plasmid could then have moved into S. aureus, where again IS1216 mediates the cointegration of the pAMb1-based plasmid with a small, mobilizable Tn4001-containing plasmid. This larger plasmid then cointegrates with a staphylococcal b-lactamase plasmid. The large size of this composite plasmid would likely be disadvantageous for the organism, leading to the deletion of various segments that did not confer selective advantage. These deletions could be readily accomplished via the movement of any of the internal insertion sequences.
Presumably, the selective advantage conferred by the resistance genes led to their surviving these different "downsizings." Conjugative transfer back to E. faecalis then occurs, followed by a final IS256-mediated deletion that results in loss not only of the transfer functions originally encoded by pAMb1 but also of the origin of replication. This final maneuver necessitates cointegration with a viable replicon for survival, resulting in an IS1216-mediated integration into the bacterial chromosome, interrupting what was deduced to be a hydrogen peroxide reductase gene and resulting in directly repeated copies of IS1216 (the expected result from an insertion sequence elementmediated cointegration) on the ends of the integrated element [15] . Obviously, the previous scenario represents but one of many pathways that would result in the final version of Tn5385 and should not be taken as a statement of fact.
Other gram-positive bacteria have exhibited similar composite chromosomal resistance regions. Strains of methicillinresistant staphylococci vary in the regions of their chromosomes that encode methicillin resistance, depending on the presence of integrated plasmid pUB110 and the positioning of IS257 and the erythromycin resistance transposon Tn554 [25] . Streptococcus pneumoniae has been shown to possess Tn5253, which is a composite of a large, mobile chloramphenicol resistance element (Tn5252) and an integrated Tn916-like conjugative transposon (Tn5251) [26] . In E. faecium, we have recently described the insertion of a Tn916-like VanB-encoding transposon immediately downstream of the pbp5 gene that encodes highlevel ampicillin resistance [3] . Both of these resistance determinants are transferable in vitro to E. faecium recipients, although the mechanisms underlying this transfer remain unclear.
In summary, the stockpiling of resistance genes in gram-positive bacteria is primarily accomplished through the activity of an array of transposons and insertion sequences. Insertion sequences, through their recombination and transposition abilities, are particularly well suited to modify existing structures in a manner that concentrates antimicrobial resistance determinants.
Transfer Mechanisms in Gram-Positive Bacteria
Resistance transfer in gram-positive bacteria is most frequently attributed to the movement of plasmids. Many of these plasmids transfer between bacteria through the activity of plasmid-encoded enzymes and are therefore considered self-transferable. Self-transferable plasmids have been shown to be important for the transfer of b-lactamase production and gentamicin resistance in E. faecalis, vancomycin resistance between enterococci, and gentamicin and mupirocin resistance in staphylococci, among others. Several classes of plasmids have been described that contribute to the spread of antimicrobial resistance genes.
Pheromone-responsive plasmids. Pheromone-responsive plasmids have been described primarily in E. faecalis and appear to have a host range that is restricted to this species [27] . They encode responses to small peptides (pheromones) that are produced by other enterococci. When a pheromone-responsive plasmid-containing bacterium comes in contact with a pheromone-producing strain, there ensues a cascade of events that leads to the production of an aggregation substance, a sticky material that causes cells to clump together (facilitating plasmid transfer). Pheromone-responsive plasmids transfer to recipient E. faecalis cells at a very high frequency, with as many as one in 10 recipient cells acquiring the plasmid. Because their host range appears to be restricted to E. faecalis, the role of pheromone-responsive plasmids in the spread of resistance genes beyond this species is unclear.
Nonpheromone-responsive conjugative plasmids. Nonpheromone-responsive conjugative plasmids have been described in several species of gram-positive bacteria. Broad host range plasmids such as pAMb1 (see above) transfer at a much lower frequency than do pheromone-responsive plasmids (∼10 Ϫ6 /recipient cfu), but, as their name implies, these plasmids are able to replicate within a wide range of species [22] . The precise mechanisms by which these plasmids transfer has not been well worked out, but they do appear to be important mechanisms for the intergeneric transfer of resistance genes. Nonpheromone-responsive plasmids that conjugate between staphylococci have been well characterized. The prototype of these plasmids is pGO1 from S. aureus [28] . pGO1 contains a region (designated trs) that encodes 10 genes involved in conjugative transfer. In pGO1, these transfer genes are flanked by copies of IS257, suggesting that they may be mobile. Several resistance genes are also found on pGO1, and these genes in turn are also flanked by copies of IS257, suggesting a very important role for this insertion element in the evolution of these plasmids. The conjugation genes in pGO1 are widespread, particularly in methicillin-resistant S. aureus strains and coagulase-negative staphylococci.
Nonconjugative mobilizable plasmids. Nonconjugative mobilizable plasmids have been best described in S. aureus. These plasmids generally contain genes (relaxase genes) that enable them to be mobilized by larger plasmids. In fact, mobilization of the staphylococcal plasmid pC221 by pGO1 was found to involve 3 different pC221 loci [29] . By virtue of their small size, mobilizable plasmids generally do not contribute more than a single antimicrobial resistance gene to a transfer event.
Conjugative transposons.
Conjugative transposons are large elements that can transfer from the donor chromosome to the recipient chromosome in the absence of a plasmid intermediate [19] . Almost all typical conjugative transposons encode tetracycline-minocycline resistance with the tet(M) gene. Exceptions to this rule include the nisin-and sucrose-containing conjugative transposons found in Lactococcus lactis and the recently described VanB-encoding Tn5382 in E. faecium. Conjugative transposons may also integrate into plasmids, allowing them to move between cells by means of the plasmid conjugation machinery. Two aspects of conjugative transposons are worthy of note regarding their involvement in gene exchange. The first is that their transfer in vitro has been shown to be enhanced (in several but not all studies) by exposure to tetracyclines [12, 30] . The second is that conjugative transfer of Tn925 (similar to that of Tn916) has been associated with the transfer of unlinked chromosomal loci (suggesting that the mechanism of transfer of these elements may involve something akin to a "cell fusion" event) [30] . As such, use of antibiotics such as tetracycline may stimulate transfer of resistance determinants in addition to the tetracycline determinants encoded by the transposons themselves.
Bacteriophage-mediated transduction. Bacteriophage-mediated transduction has been postulated to be the primary mechanism by which b-lactamase genes have spread among staphylococci. Supportive of this mechanism is the fact that most b-lactamase-producing plasmids are 35-40 kb in size or roughly the size of a bacteriophage genome [31] . As such, the mistaken incorporation of the plasmid into the bacteriophage head (generalized transduction) could be facilitated. The involvement of transduction in the transfer of other resistance determinants is not well defined, but they have been implicated as vectors for the dissemination of virulence determinants [32] .
Transformation. The ability to absorb free DNA from the environment is relatively rare in species of gram-positive bacteria. One very important species that has used this technique to become resistant is S. pneumoniae [33] . Penicillin resistance in S. pneumoniae results from the uptake of penicillin-binding protein genes (presumably left in the environment of the human oropharynx by dead and decayed viridans streptococci) that encode proteins with a lower affinity for penicillin than those encoded by the native S. pneumoniae penicillin-binding protein genes. Under the appropriate conditions, pieces of these absorbed genes can recombine with the native S. pneumoniae penicillin-binding protein genes. If the recombination results in a functional penicillin-binding protein, then decreased susceptibility to penicillin results.
Unexplained transfer mechanisms. There remain examples of chromosome-to-chromosome gene exchange for which mechanisms have not been elucidated. These examples include transfer of Tn5385 (described above) between E. faecalis strains and transfer of the vancomycin and ampicillin resistance element described in E. faecium. In the case of Tn5385, transfer appears to occur by at least 2 different mechanisms, one of which is homologous recombination between flanking donor and recipient chromosomal sequences [15] .
The many and varied structures and mechanisms of transfer exhibited by elements containing antimicrobial resistance determinants, which are summarized in figure 2, make it clear that strict notions regarding structures and their functions are no longer useful. Plasmids may be independently replicating or integrated into the chromosomes. They may be transferable on their own, mobilizable, or not transferable at all. Resistance determinants may not be transposable one day but readily transposable the next day by virtue of the strategic placement of an insertion element or two. Chromosomal genes may be transferable because of their incorporation within an integrated plasmid or conjugative transposon or even in the absence of incorporation into a transposon if there happens to be a conjugative transposon present elsewhere in the genome. In summary, bacterial genomes are plastic, dynamic structures that have a wealth of resources to draw on to respond to environmental challenges.
Implications for the Clinician
The diversity of mechanisms by which gram-positive bacteria share genetic material make it patently obvious that strategies designed to interrupt a specific mechanism of transfer, if they could be devised, would be unlikely to exert a significant impact on the prevalence of resistant bacteria in the modern day hospital. An appreciation of this variation raises two important and intriguing questions: why are not all bacteria now multidrug-resistant and why do some organisms remain highly susceptible to certain antibiotics despite tremendous antimicrobial selective pressure?
It is not clear why most bacteria remain susceptible to many antibiotics. It is reasonable to assume (although there are scant experimental data to support it) that the expression of antimicrobial resistance genes or the active suppression of inducible genes carry metabolic costs to the host organism. Therefore, in a setting where the resistance determinant does not confer a selective advantage (i.e., in the absence of antibiotic selective pressure), its loss could be favored. The presence of insertion sequence elements, plasmids, and transposons could even facilitate loss of the resistance determinants under these conditions, since these mobile elements can mediate deletion as well as incorporation of DNA segments [34] . The possibility that loss is favored in the absence of selective pressure (or that more susceptible and intrinsically "fit" strains take over in an antibiotic-free environment) increases the importance of prudent use of antimicrobial agents throughout the food chain. It is somewhat ironic that the explosion of detailed molecular knowledge about the mechanisms of resistance and resistance transfer leads us back to the same conclusion drawn when resistant bacteria were first recognized-parsimonious use of antimicrobial agents is the best defense against resistance. The observation that certain types of resistance do not appear in specific genera despite enormous antimicrobial selective pressure suggests that there is much still to be learned about the spread of antibiotic resistance. For example, why has b-lactamase-mediated penicillin resistance never appeared in S. pneumoniae or, in fact, in any streptococci? The sole nonstaphylococcal species to acquire the staphylococcal b-lactamase gene is Enterococcus. Despite initial concerns, b-lactamase acquisition by Enterococcus has been rare and almost always accompanied by a deletion or inactivation of the regulatory genes that control b-lactamase expression [24] . It is conceivable that Enterococcus and, presumably, streptococci do not tolerate the b-lactamase regulation mechanism, which involves a transmembrane sensor and cytoplasmic repressor [35] . By analogy, it is conceivable that the failure to observe vancomycin resistance determinants in staphylococci represents an inability on the part of staphylococci to tolerate some aspect of the mechanism of vancomycin resistance. One thing is clear: barriers that may prevent the acquisition of specific resistance determinants by certain species are not barriers to entry, since the presence of identical resistance genes and transposons in disparate genera has been well documented. As such, the appearance of any important resistance determinant in a grampositive bacterium should be cause for alarm, at least until sufficient time has elapsed to suggest that the determinant will not spread widely.
Conclusion
Multidrug-resistant bacteria have evolved into the nosocomial equivalent of the modern day monopolist. To serve patients' needs, we must use antibiotics. The unavoidable cost of antimicrobial use is the emergence and spread of antimicrobial resistance. Unfortunately, bacteria have evolved in a manner that precludes any choice on our parts regarding the resistance determinants we are buying with our antimicrobial use. By "bundling" their resistance determinants, human pathogenic bacteria have forced us to accept resistance on their terms, terms that are in many cases unfavorable to us. Because there is no governmental structure to force an unbundling of resistance determinants, our best hope for reversing this trend will be to exert harsh economic pressure on the monopolists. As much as possible and consistent with first-rate medical care of sick patients, we must starve these bacteria of the lifeblood that promotes their persistence-the unrelenting selective pressure exerted by overuse of antibiotics.
